Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis
Trial ID or NCT#
NCT02387853
Status
NOT RECRUITING
Purpose
An international, multi-centre, prospective, open-label, non-controlled, single-group, 4-week trial in adolescent subjects with plaque psoriasis.
Official Title
Safety and Effect of LEO 90100 Aerosol Foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to < 17 Years) With Plaque Psoriasis
Eligibility Criteria
Ages Eligible for Study: 12 Years to 17 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Exclusion Criteria:
Investigator(s)
Joyce Teng, MD, PhD
Dermatologist,
Pediatric dermatologist
Professor of Dermatology and, by courtesy, of Pediatrics
Contact us to find out if this trial is right for you.
Contact
Elidia Tafoya
650-724-1982
View on